Giorgia M.
- Country
- Italy
- Department
- Ginecologia e Ostetricia
Research Overview
- Phase 3 Study Comparing Rinatabart Sesutecan Versus Investigator's Choice in Patients With Recurrent or Progressive Endometrial Cancer Following Platinum-Based and PD(L)-1 Therapy
- Phase 3 Randomized Open-Label Trial of Tisotumab Vedotin Versus Chemotherapy in Second- or Third-Line Recurrent or Metastatic Cervical Cancer
- INCMGA 0012-204: An Umbrella Study of INCMGA00012 Alone and in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-Based Chemotherapy (POD1UM-204)
Data & Insights
Has run more than one trial at 201 of 401 partner sites.
Specializations
Gynecologic Oncology - Primary Focus
The investigator specializes in treating advanced gynecologic malignancies, with particular emphasis on developing innovative therapeutic approaches for various forms of endometrial cancer and ovarian cancer.
- Advanced and Recurrent Endometrial Cancer
- High-Grade Epithelial Ovarian Cancer
- Low-Grade Serous Ovarian Cancer
Targeted Therapies
Focuses on evaluating novel targeted treatments including PARP inhibitors and immunotherapy agents for gynecologic cancers. Investigates maintenance therapy approaches using innovative drug combinations.
- Biomarker-Driven Treatment Strategies
- Maintenance Therapy Protocols
- Combination Therapy Approaches
Cervical Cancer Research
Conducts research in advanced cervical cancer treatment, investigating both early-stage therapeutic interventions and management of metastatic disease using novel therapeutic agents.
- Locally Advanced Cervical Cancer
- Recurrent/Metastatic Disease
- Chemoradiotherapy Combinations
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.